Replies to post #114033 on Biotech Values

[DewDiligence]

Brilinta has lower price/QALY than generic Plavix, according to AZN and Swedish researchers:

http://www.reuters.com/article/2011/05/09/astrazeneca-brilinta-idUSLDE7481CO20110509

The study compared Brilinta at its market price to generic Plavix at €0.17/day. (Plavix is already off-patent in many European countries.)